Publications
101
Citations
681
Est. group size
—
Recurring co-author estimate
Active years
12
Publishing since 2015
Typically publishes in teams of ~3 · 52% small-team papers (≤3 authors) · across 10 venues
- A review of targeted drug delivery with antibody-drug complexes
Journal of Pharmacology and Experimental Therapeutics · 2025
- Investigations of Influence of Antibody Binding Kinetics on Tumor Distribution and Anti-Tumor Efficacy
The AAPS Journal · 2025
- Improving the Therapeutic Selectivity of Trastuzumab Deruxtecan Using 8C2 Fab Fragments
The AAPS Journal · 2025
- Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin
Cancers · 2025
- Supplementary Figure 1 from Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
2025
- Supplementary Table 2 from Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
2025
- Supplementary Table 1 from Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
2025
- Supplementary Figure 2 from Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
2025
- Supplementary Figure 3 from Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
2025
- Increasing the therapeutic index of ADCs with payload binding selectivity enhancers
Drug Metabolism and Pharmacokinetics · 2024
- Table S1 from Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
2024
- Supplementary Data from Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
2024
- Figure S4 from Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
2024
- Figure S5 from Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
2024
- Figure S1 from Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates
2024
- Molecular Cancer Therapeutics×3
- The AAPS Journal×3
- Cancers×2
- Cancer Research×2
- International Journal of Molecular Sciences×2
- Eshita Khera
Medicine · University of Michigan
- Jiashuai Zhang
Medicine · The Ohio State University
- Dong Jun Koo
Medicine · University of Michigan
- Daniel C. Koboldt
Medicine · The Ohio State University
- Keith Miller
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile